Trials / Unknown
UnknownNCT02072785
Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia
Phase III Study of Vincristine Sulfate Liposome Or Vincristine Sulfate For Injection Combined Chemotherapy as Initial Induction Regimen In Adults Acute Lymphoblastic Leukemia
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 480 (estimated)
- Sponsor
- Nanjing Luye Sike Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether vincristine sulfate liposome could reduce less peripheral neuropathy than vincristine sulfate,and be as effective as vincristine sulfate in adults with Naïve Acute Lymphoblastic Leukemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vincristine Sulfate Liposome | |
| DRUG | Vincristine Sulfate |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2014-02-27
- Last updated
- 2014-03-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02072785. Inclusion in this directory is not an endorsement.